Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
-48,044
% of shares
-75.73%
Amount (USD)
$735,073
Insider confidence score
10.0 out of 100
Positive
Negative
Security
Common Stock
Action
Exercise
Date
2026-03-03
Code
M
Net shares
+48,044.0
Price per Share
$3.99
Amount (USD)
$191,695.56
Acquired/Disposed
Acquired
Shares Owned Before
15,394.0
Shares Owned After
63,438.0
Security
Common Stock
Action
Sell
Date
2026-03-03
Code
S
Net shares
-48,044.0
Price per Share
$15.30
Amount (USD)
$735,073.20
Acquired/Disposed
Disposed
Shares Owned Before
63,438.0
Shares Owned After
15,394.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-03
Code
M
Net shares
-48,044.0
Acquired/Disposed
Disposed
Shares Owned Before
48,044.0
Shares Owned After
0.0
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025.
2. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.11 to $15.54, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
3. The option is fully vested and exercisable.
ℹ️ Filed under Rule 10b5-1 trading plan
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.